Extra pyramidal side effects associated with paroxetine

Area of Science:

• Psychiatry
• Clinical Pharmacology
• Neuroscience

Background:

• Paranoid psychosis is a serious mental health condition requiring effective pharmacotherapy.
• Trifluoperazine is a typical antipsychotic medication used for managing psychotic disorders.
• Paroxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression and anxiety.

Observation:

• A patient with paranoid psychosis initially responded well to trifluoperazine treatment.
• Upon reducing trifluoperazine dosage and adding paroxetine, the patient experienced severe extra-pyramidal side effects.
• These adverse effects subsided after discontinuing all psychotropic medications and did not reappear when trifluoperazine was restarted.

Findings:

• This case report details the first instance of severe extra-pyramidal side effects potentially linked to paroxetine administration in a patient with paranoid psychosis.
• The findings suggest a possible interaction or direct effect of paroxetine contributing to these neurological adverse events.

Implications:

• Clinicians should be vigilant for extra-pyramidal side effects when prescribing paroxetine, especially in patients with a history of antipsychotic use.
• Further research is warranted to elucidate the mechanism underlying paroxetine-induced extra-pyramidal symptoms and its potential interaction with antipsychotics.
• This case highlights the importance of careful medication management and monitoring for adverse drug reactions in psychiatric patients.